Error loading player: No playable sources found
2090
Insights into Pathogenesis, Diagnosis, and Management of Clostridioides difficile Colitis
Date
May 18, 2024
SOCIETY: AGA This session will feature cutting-edge research on the multifaceted aspects of Clostridioides difficile colitis, presenting the latest findings in pathogenesis and innovative therapeutic approaches. Attendees will gain valuable insights into the molecular and immunological aspects of C. difficile infection. The session will also address emerging therapeutic options using different forms of fecal microbiota transplanation and defined microbial consortia.
Presentation:
| SINGLE-CELL RNA PROFILING AND HIGH-THROUGHPUT SCREENING DISCOVERED MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA AND HISTAMINE 1 RECEPTOR AS KEY PATHWAYS IN C. DIFFICILE INFECTION. |
| EFFECTS OF LYOPHILIZED FECAL FILTRATE COMPARED TO LYOPHILIZED DONOR STOOL IN THE TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTI-CENTER, DOUBLE-BLINDED RANDOMIZED TRIAL |
| PATIENT OUTCOMES OF INTESTINAL MICROBIOTA TRANSPLANTATION FOR SEVERE AND FULMINANT CLOSTRIDIOIDES DIFFICILE INFECTION: RESULTS FROM A NATIONAL REGISTRY. |
| ORAL CAPSULE FMT COMBINED WITH BEZLOTOXUMAB IS A SUCCESSFUL RESCUE PROTOCOL FOLLOWING FAILURE OF FMT ALONE IN TREATMENT OF RECURRENT C. DIFFICILE INFECTION |
| RECOVERY OF MICROBIOME FUNCTIONAL PATHWAYS INVOLVED IN STICKLAND FERMENTATION IN PATIENTS RECEIVING VE303, A DEFINED BACTERIAL CONSORTIUM FOR CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) |
| CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES MUC5AC EXPRESSION IN MICE AND HUMANS AND ALTERS THE MUCOSAL GLYCAN COMPOSITION |
| A MULTIVALENT NUCLEOSIDE-MODIFIED MRNA-LNP VACCINE FOR CLOSTRIDIODIES DIFFICILE |
Moderators
Brigham and Women's Hospital
Brigham and Women's Hospital
Related Products
Battling the Bloat: Practical Approaches to One of Gastroenterology's Most Vexing Complaints
LIVE STREAM SESSION DDW attendees will find both a practical approach to treating patients with abdominal bloating and distention using multi-modal therapies and an approachable scientific rationale for our current understanding of bloating and distention…
AGA How Do We End the Arms Race Between Commensals and Opportunistic Pathogens in the Gut?
The gastrointestinal tract is a diverse and complex ecosystem shaped by continual interactions between host cells, nutrients, and the gut microbiota. Under homeostatic conditions, the human gut microbiota limits the growth of pathogenic bacteria and restricts the influence of resident pathobionts…
AGA Barry Marshall (Nobel Laureate 2005) and Adrienne Marshall Lecture: Helicobacter Pylori Management: The Ongoing Uncertainties
40 years after the organism was first recognized and grown in culture, Helicobacter pylori infections are still commonly encountered in practice,. This symposium will focus on several areas that remain unresolved to this day - including how best to manage H…
